RxDoctor Payments Data

Megumi Maguchi Aldrete, MD

Geriatric Medicine · Pensacola, FLNPI 1417261991

Payments from drug & device makers

$954in general payments, 2019–2025

Across 39 payments — averaging $24.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$188
  • Lilly USA, LLC$157
  • Sunovion Pharmaceuticals Inc.$136
  • AstraZeneca$123
  • Acadia Pharmaceuticals Inc$112
  • Sun Pharmaceutical Industries Inc.$51
  • plus $187 from 7 others

What the payments were for

  • Food & beverage$954100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$954 in reported general payments places this provider in the 70th percentile of 305 geriatric medicine providers in Florida.

See all geriatric medicine providers in Florida

Medicare billing

Part B allowed, 2024
$46,982
Medicare patients
184
Services billed
447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban40$46,096
TrulicityDulaglutide16$23,434
XareltoRivaroxaban19$22,552
NuedextaDextromethorphan Hbr/Quinidine12$15,740
JardianceEmpagliflozin17$13,343
OzempicSemaglutide13$12,803
DapagliflozinDapagliflozin Propanediol18$9,351
Losartan Potassium264$4,102
Pantoprazole Sodium54$3,572
Atorvastatin Calcium219$3,551
Rosuvastatin Calcium117$2,699
Omeprazole85$2,646
Donepezil Hcl81$2,513
Memantine Hcl44$2,225
Levothyroxine Sodium133$1,997

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$27$46,09640 claims
Lilly USA, LLCTrulicity$157$23,43416 claims
Johnson & JohnsonXarelto$188$22,55219 claims
Avanir Pharmaceuticals, Inc.Nuedexta$50$15,74012 claims
AbbVieSynthroid$26$1,97017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 305 geriatric medicine providers in Florida.

Other geriatric medicine in Pensacola

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →